Sign In
Buy BDTX
$1.61
-0.0500 (-3.01%)
At Close: Jun 22, 2026
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
08:00am, Tuesday, 07'th Nov 2023
CAMBRIDGE, Mass. and NEW YORK, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families
Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
07:45am, Monday, 06'th Nov 2023
CAMBRIDGE, Mass. and NEW YORK, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families
Initial results from BDTX-1535 dose escalation show durable activity in patients with NSCLC across heterogeneous EGFR mutation subtypes
CAMBRIDGE, Mass. and NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology company developing therapies that target families
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
08:00am, Tuesday, 05'th Sep 2023
CAMBRIDGE, Mass. and NEW YORK, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology company developing MasterKey therapies that targe
Why Shares of Black Diamond Therapeutics Skyrocketed This Week
05:48pm, Thursday, 29'th Jun 2023
Lung cancer is the deadliest form of cancer in the U.S. Black Diamond Therapeutics' NSCLC therapy is in early trials. The pharmaceutical company used the positive news to raise funds through a stock s
Black Diamond Therapeutics stock rockets after positive trial data shows anti-tumor activity
11:56am, Tuesday, 27'th Jun 2023
Black Diamond Therapeutics Inc shares doubled after it saw positive initial dose escalation data from a study demonstrating the anti-tumor activity of BDTX-1535 in non-small cell lung (NSCL) cancer pa
Why Is Black Diamond Therapeutics (BDTX) Stock Up 82%?
11:00am, Tuesday, 27'th Jun 2023
Black Diamond Therapeutics (NASDAQ: BDTX ) stock is seeing massive gains on Tuesday after releasing data from the dose escalation portion of the Phase 1 clinical study. That clinical trial covers the
Black Diamond Therapeutics to Present at the Jefferies Healthcare Conference
08:00am, Friday, 02'nd Jun 2023
CAMBRIDGE, Mass. and NEW YORK, June 02, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology medicine company developing MasterKey therapies de
Black Diamond Therapeutics to Present at the Cowen 43rd Annual Health Care Conference
08:00am, Monday, 27'th Feb 2023
CAMBRIDGE, Mass. and NEW YORK, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology medicine company developing novel MasterKey therap
Black Diamond Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
08:00am, Thursday, 05'th Jan 2023
CAMBRIDGE, Mass. and NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology medicine company developing MasterKey therapies de
Down 32.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Black Diamond (BDTX)
11:17am, Friday, 09'th Dec 2022
Black Diamond (BDTX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estim
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
08:00am, Wednesday, 09'th Nov 2022
CAMBRIDGE, Mass. and NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of Mast
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
08:00am, Tuesday, 06'th Sep 2022
CAMBRIDGE, Mass. and NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of Mas
Black Diamond Therapeutics to Present at the 2022 Wedbush PacGrow Healthcare Virtual Conference
08:00am, Wednesday, 03'rd Aug 2022
CAMBRIDGE, Mass. and NEW YORK, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of Mast
